87 related articles for article (PubMed ID: 16740732)
21. A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.
Ebert LM; Liu YC; Clements CS; Robson NC; Jackson HM; Markby JL; Dimopoulos N; Tan BS; Luescher IF; Davis ID; Rossjohn J; Cebon J; Purcell AW; Chen W
Cancer Res; 2009 Feb; 69(3):1046-54. PubMed ID: 19176376
[TBL] [Abstract][Full Text] [Related]
22. In vitro induction of immune responses to shared tumor-associated antigens in rhabdomyosarcoma.
Rodeberg DA; Erskine C; Celis E
J Pediatr Surg; 2007 Aug; 42(8):1396-402. PubMed ID: 17706503
[TBL] [Abstract][Full Text] [Related]
23. The deleterious G15498A mutation in mitochondrial DNA-encoded cytochrome b may remain clinically silent in homoplasmic carriers.
Haut S; de Villemeur TB; Brivet M; Guiochon-Mantel A; Boutron A; Rustin P; Legrand A; Slama A
Eur J Hum Genet; 2004 Mar; 12(3):220-4. PubMed ID: 14735157
[TBL] [Abstract][Full Text] [Related]
24. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
25. NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
Maccalli C; Nonaka D; Piris A; Pende D; Rivoltini L; Castelli C; Parmiani G
Clin Cancer Res; 2007 Dec; 13(24):7459-68. PubMed ID: 18094430
[TBL] [Abstract][Full Text] [Related]
26. Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas.
Mithani SK; Smith IM; Topalian SL; Califano JA
Melanoma Res; 2008 Jun; 18(3):214-9. PubMed ID: 18477896
[TBL] [Abstract][Full Text] [Related]
27. Chapter 27 An improved method for introducing point mutations into the mitochondrial cytochrome B gene to facilitate studying the role of cytochrome B in the formation of reactive oxygen species.
Ding MG; Butler CA; Saracco SA; Fox TD; Godard F; di Rago JP; Trumpower BL
Methods Enzymol; 2009; 456():491-506. PubMed ID: 19348906
[TBL] [Abstract][Full Text] [Related]
28. Detection of unrecognized low-level mtDNA heteroplasmy may explain the variable phenotypic expressivity of apparently homoplasmic mtDNA mutations.
Ballana E; Govea N; de Cid R; Garcia C; Arribas C; Rosell J; Estivill X
Hum Mutat; 2008 Feb; 29(2):248-57. PubMed ID: 17999439
[TBL] [Abstract][Full Text] [Related]
29. In vivo anti-melanoma activities of the Melan-A/MART-1(101-115) T CD4+ cell peptide.
Balasse E; Gatouillat G; Patigny D; Andry MC; Madoulet C
Vaccine; 2009 Oct; 27(44):6107-9. PubMed ID: 19686694
[TBL] [Abstract][Full Text] [Related]
30. Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.
Pieper R; Christian RE; Gonzales MI; Nishimura MI; Gupta G; Settlage RE; Shabanowitz J; Rosenberg SA; Hunt DF; Topalian SL
J Exp Med; 1999 Mar; 189(5):757-66. PubMed ID: 10049939
[TBL] [Abstract][Full Text] [Related]
31. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
[TBL] [Abstract][Full Text] [Related]
32. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial mutations in cancer.
Brandon M; Baldi P; Wallace DC
Oncogene; 2006 Aug; 25(34):4647-62. PubMed ID: 16892079
[TBL] [Abstract][Full Text] [Related]
34. Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma.
Weber J; Boswell W; Smith J; Hersh E; Snively J; Diaz M; Miles S; Liu X; Obrocea M; Qiu Z; Bot A
J Immunother; 2008; 31(2):215-23. PubMed ID: 18481391
[TBL] [Abstract][Full Text] [Related]
35. The human immune system recognizes neopeptides derived from mitochondrial DNA deletions.
Duvvuri B; Duvvuri VR; Wang C; Chen L; Wagar LE; Jamnik V; Wu J; Yeung RS; Grigull J; Watts TH; Wu GE
J Immunol; 2014 May; 192(10):4581-91. PubMed ID: 24733843
[TBL] [Abstract][Full Text] [Related]
36. Novel primers for complete mitochondrial cytochrome b gene sequencing in mammals.
Naidu A; Fitak RR; Munguia-Vega A; Culver M
Mol Ecol Resour; 2012 Mar; 12(2):191-6. PubMed ID: 21974833
[TBL] [Abstract][Full Text] [Related]
37. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients.
Takeuchi H; Fujimoto A; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():50-4. PubMed ID: 15251939
[TBL] [Abstract][Full Text] [Related]
38. Non-random base composition in codons of mitochondrial cytochrome b gene in vertebrates.
Prusak B; Grzybowski T
Acta Biochim Pol; 2004; 51(4):897-905. PubMed ID: 15625561
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation.
Tarnopolsky MA; Simon DK; Roy BD; Chorneyko K; Lowther SA; Johns DR; Sandhu JK; Li Y; Sikorska M
Muscle Nerve; 2004 Apr; 29(4):537-47. PubMed ID: 15052619
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial DNA segregation in hematopoietic lineages does not depend on MHC presentation of mitochondrially encoded peptides.
Battersby BJ; Redpath ME; Shoubridge EA
Hum Mol Genet; 2005 Sep; 14(17):2587-94. PubMed ID: 16049030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
